COMPASS Pathways plc (CMPS) — Stock Score Summary

COMPASS Pathways plc (CMPS) has a MoatMap StockRank of 62/100 based on Quality (40/100), Value (35/100), and Momentum (72/100) factor scores. The current signal is HOLD. COMPASS Pathways is a pre-revenue biotech firm with binary clinical trial risk, which directly violates our Terry Smith lens of owning established, high-ROIC compounders.

COMPASS Pathways plc is a mental healthcare company dedicated to accelerating patient access to evidence-based innovation in mental health, primarily focusing on psilocybin therapy for treatment-resistant depression. The company is at the forefront of researching and developing psilocybin as a regulated medicine, navigating complex regulatory pathways and clinical trials. Its leadership in this emerging therapeutic area provides a significant first-mover advantage and a distinct competitive position.

Key Financial Metrics

Price$11.26
Market Cap$1.6B
P/E (Forward)-12.35
Price/Book5.39
Return on Equity-68.5%
Debt/Equity16.32
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$33M

COMPASS Pathways plc operates in the Medical Care Facilities industry, part of the Healthcare sector (United Kingdom).

Frequently Asked Questions

What is COMPASS Pathways plc’s (CMPS) StockRank?
MoatMap’s StockRank for COMPASS Pathways plc (CMPS) is 62/100, with a Hold signal. It is a composite of Quality (40), Value (35), and Momentum (72) factor ranks across MoatMap’s 19,000+ stock universe.
Does COMPASS Pathways plc have an economic moat?
COMPASS Pathways plc (CMPS) has a Quality factor score of 40/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is COMPASS Pathways plc a buy, hold, or sell?
MoatMap’s current signal for COMPASS Pathways plc (CMPS) is Hold, based on a StockRank of 62/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is COMPASS Pathways plc in?
COMPASS Pathways plc (CMPS) operates in the Healthcare sector, specifically the Medical Care Facilities industry (United Kingdom).
Browse all ranked stocksCMPS deep dive reportAI ChampionsHow we score stocksSense-check another stock